The BBI Diagnostics Group has been a trusted partner to some of the world’s leading diagnostic and healthcare organisations for over 25 years. Founded upon the success of the superior quality and performance of their gold reagents, the organisation has grown to incorporate 3 businesses delivering excellence in diagnostic assay development and manufacturing across a range of sectors, and the supply of consumer healthcare products.
The BBI Group offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defence and food industries globally.
The BBI Group now employs over 450 members of staff across 7 global facilities.
In 2015, The BBI Group announced the completion of the acquisition by Exponent, a private equity firm that's focused on creating world-class UK businesses.